老年非小细胞肺癌患者化疗后细胞免疫功能的变化

被引:16
作者
王兴春
机构
[1] 临沂市肿瘤医院肿瘤内科
关键词
非小细胞肺癌; 化疗; 免疫;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100117 [系统生物医学];
摘要
目的探讨老年非小细胞肺癌(NSCLC)患者化疗后细胞免疫功能变化。方法 58例老年NSCLC患者纳入研究,同期的50例中青年NSCLC患者以及52例健康老年人作为对照,比较化疗前后老年NSCLC患者各项免疫功能指标变化。结果与中青年组比较,老年患者的CD3、CD4、CD4/CD8显著降低(t=4.89,4.88,2.69,P<0.05),白细胞介素(IL)-12显著升高(t=2.16,P<0.05);与健康老人相比,老年患者的CD3、CD4、CD4/CD8、自然杀伤细胞(NK)显著降低(t=6.63,5.33,3.72,5.67,P<0.05),干扰素(IFN-γ)、IL-12显著升高(t=6.26,4.70,P<0.05);化疗前后比较,化疗后CD3显著降低(t=5.81,P<0.05)。结论化疗对患者的免疫功能有一定影响,要及时对老年化疗患者的近期结果进行评价,选择合适的化疗时机。
引用
收藏
页码:1796 / 1797
页数:2
相关论文
共 12 条
[1]
Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer [J].
Yuan Yuanying ;
Niu Lizhi ;
Mu Feng ;
Wang Xiaohua ;
Zeng Jianying ;
Yao Fei ;
Jiang Feng ;
He Lihua ;
Chen Jibing ;
Li Jialiang ;
Xu Kecheng .
CRYOBIOLOGY, 2013, 67 (02) :235-240
[2]
A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial) [J].
Westeel, Virginie ;
Quoix, Elisabeth ;
Puyraveau, Marc ;
Lavole, A. ;
Braun, Denis ;
Laporte, Silvy ;
Bigay-Game, Laurence ;
Pujol, Jean-Louis ;
Ozenne, Gervais ;
Riviere, Alain ;
Douillard, Jean-Yves ;
Lebeau, Bernard ;
Debieuvre, Didier ;
Poudenx, Michel ;
David, Philippe ;
Molinier, Olivier ;
Zalcman, Gerard ;
Lemarie, Etienne ;
Morin, Franck ;
Depierre, Alain ;
Milleron, Bernard .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (12) :2654-2664
[3]
Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non–Small-Cell Lung Cancer.[J].Hai-bo Sun;Wei Ou;Yin Li;Qin Fang;Jianjun Qin;Liang Zhang;Si-yu Wang.Clinical Lung Cancer.2013, 4
[4]
A Multicenter Randomized Phase IIb Efficacy Study of Vx-001; a Peptide-Based Cancer Vaccine as Maintenance Treatment in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics.[J].Vassilis Georgoulias;Jean-Yves Douillard;David Khayat;Christian Manegold;Rafael Rosell;Antonio Rossi;Jeanne Menez-Jamet;Marina Iché;Kostas Kosmatopoulos;Cesare Gridelli.Clinical Lung Cancer.2013, 4
[5]
Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non–Small-Cell Lung Cancer.[J].Wei-Yu Liao;Jin-Hsin Chen;Muzo Wu;Jin-Yuan Shih;Kuan-Yuh Chen;Chao-Chi Ho;James Chih-Hsin Yang;Chong-Jen Yu.Clinical Lung Cancer.2013, 4
[6]
The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer [J].
Lohr, Miriam ;
Edlund, Karolina ;
Botling, Johan ;
Hammad, Seddik ;
Hellwig, Birte ;
Othman, Amnah ;
Berglund, Anders ;
Lambe, Mats ;
Holmberg, Lars ;
Ekman, Simon ;
Bergqvist, Michael ;
Ponten, Fredrik ;
Cadenas, Cristina ;
Marchan, Rosemarie ;
Hengstler, Jan G. ;
Rahnenfuehrer, Joerg ;
Micke, Patrick .
CANCER LETTERS, 2013, 333 (02) :222-228
[7]
Effects of surgery, general anesthesia, and perioperative epidural analgesia on the immune function of patients with non-small cell lung cancer [J].
Cata, Juan P. ;
Bauer, Maria ;
Sokari, Telemate ;
Ramirez, Maria F. ;
Mason, David ;
Plautz, Gregory ;
Kurz, Andrea .
JOURNAL OF CLINICAL ANESTHESIA, 2013, 25 (04) :255-262
[8]
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network [J].
Ritzwoller, Debra P. ;
Carroll, Nikki M. ;
Delate, Thomas ;
Hornbrook, Mark C. ;
Kushi, Lawrence ;
Bowles, Erin J. Aiello ;
Freml, Jared M. ;
Huang, Karl ;
Loggers, Elizabeth T. .
LUNG CANCER, 2012, 78 (03) :245-252
[9]
Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy [J].
Salloum, Ramzi G. ;
Smith, Thomas J. ;
Jensen, Gail A. ;
Lafata, Jennifer Elston .
LUNG CANCER, 2012, 77 (03) :545-549
[10]
IL-23 is pro-proliferative; epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer.[J].Anne-Marie Baird;Jennifer Leonard;Krisha M. Naicker;Lisa Kilmartin;Kenneth J. O’Byrne;Steven G. Gray.Lung Cancer.2012,